334 related articles for article (PubMed ID: 26626571)
1. New Strategies in Stereotactic Radiotherapy for Oligometastases.
Palma DA; Louie AV; Rodrigues GB
Clin Cancer Res; 2015 Dec; 21(23):5198-204. PubMed ID: 26626571
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiotherapy in oligometastatic cancer.
Kennedy TAC; Corkum MT; Louie AV
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S16. PubMed ID: 28917254
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
Olson R; Mathews L; Liu M; Schellenberg D; Mou B; Berrang T; Harrow S; Correa RJM; Bhat V; Pai H; Mohamed I; Miller S; Schneiders F; Laba J; Wilke D; Senthi S; Louie AV; Swaminath A; Chalmers A; Gaede S; Warner A; de Gruijl TD; Allan A; Palma DA
BMC Cancer; 2020 May; 20(1):380. PubMed ID: 32370765
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
[TBL] [Abstract][Full Text] [Related]
5. The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?
Hong JC; Salama JK
Cancer Treat Rev; 2017 Jan; 52():22-32. PubMed ID: 27886588
[TBL] [Abstract][Full Text] [Related]
6. The emerging roles of stereotactic ablative radiotherapy for metastatic renal cell carcinoma.
Cheung P; Thibault I; Bjarnason GA
Curr Opin Support Palliat Care; 2014 Sep; 8(3):258-64. PubMed ID: 25090288
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy for oligometastatic disease.
Hanna GG; Landau D
Clin Oncol (R Coll Radiol); 2015 May; 27(5):290-7. PubMed ID: 25770653
[TBL] [Abstract][Full Text] [Related]
8. New concepts and insights into the role of radiation therapy in extracranial metastatic disease.
Ricardi U; Filippi AR; Franco P
Expert Rev Anticancer Ther; 2013 Oct; 13(10):1145-55. PubMed ID: 24134418
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
Palma DA; Olson R; Harrow S; Correa RJM; Schneiders F; Haasbeek CJA; Rodrigues GB; Lock M; Yaremko BP; Bauman GS; Ahmad B; Schellenberg D; Liu M; Gaede S; Laba J; Mulroy L; Senthi S; Louie AV; Swaminath A; Chalmers A; Warner A; Slotman BJ; de Gruijl TD; Allan A; Senan S
BMC Cancer; 2019 Aug; 19(1):816. PubMed ID: 31426760
[TBL] [Abstract][Full Text] [Related]
10. Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases.
Saluja R; Cheung P; Zukotynski K; Emmenegger U
Urol Oncol; 2016 May; 34(5):225-32. PubMed ID: 27008982
[TBL] [Abstract][Full Text] [Related]
11. The evolving role of radiotherapy in treatment of oligometastatic NSCLC.
Bergsma DP; Salama JK; Singh DP; Chmura SJ; Milano MT
Expert Rev Anticancer Ther; 2015; 15(12):1459-71. PubMed ID: 26536370
[TBL] [Abstract][Full Text] [Related]
12. [Stereotactic body radiation therapy and oligometastases].
Bourgier C; Azria D; Fenoglietto P; Riou O; Almaghrabi MY; Supiot S; Mornex F; Giraud P
Cancer Radiother; 2014; 18(4):337-41. PubMed ID: 24792996
[TBL] [Abstract][Full Text] [Related]
13. Radiation in the Treatment of Oligometastatic and Oligoprogressive Disease: Rationale, Recent Data, and Research Questions.
Zayed S; Correa RJM; Palma DA
Cancer J; 2020; 26(2):156-165. PubMed ID: 32205541
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiotherapy for pulmonary metastases.
Chmura SJ; Salama JK; Weichselbaum RR
Semin Thorac Cardiovasc Surg; 2013; 25(4):292-9. PubMed ID: 24673958
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic ablative body radiotherapy for lung cancer.
Franks KN; Jain P; Snee MP
Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
[TBL] [Abstract][Full Text] [Related]
16. Adrenal oligometastasis cured with stereotactic ablative radiotherapy.
Malone J; Pantarotto JR; Tiberi D; Malone S
Radiol Case Rep; 2020 Nov; 15(11):2266-2270. PubMed ID: 32983297
[TBL] [Abstract][Full Text] [Related]
17. Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases.
Conde-Moreno AJ; Lopez-Guerra JL; Macias VA; Vázquez de la Torre ML; Samper Ots P; San José-Maderuelo S; Pastor Peidro J; López-Torrecilla J; Expósito-Hernández J
Clin Transl Oncol; 2016 Apr; 18(4):342-51. PubMed ID: 26329294
[TBL] [Abstract][Full Text] [Related]
18. SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer.
Westover KD; Iyengar P; Sharma AN; Timmerman R
Lung Cancer; 2015 Aug; 89(2):87-93. PubMed ID: 26028304
[TBL] [Abstract][Full Text] [Related]
19. Oligometastases: history of a hypothesis.
Milano MT; Biswas T; Simone CB; Lo SS
Ann Palliat Med; 2021 May; 10(5):5923-5930. PubMed ID: 32279519
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic Radiotherapy for Oligometastasis.
Otake S; Goto T
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30678111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
